European Journal of Nutrition

, Volume 52, Issue 2, pp 601–608 | Cite as

Chlorella pyrenoidosa ameliorated L-NAME-induced hypertension and cardiorenal remodeling in rats

  • Su-Ching Yang
  • Hsin-Yi YangEmail author
  • Yi-Ching Yang
  • Hsiang-Chi Peng
  • Pei-Yin Ho
Original Contribution



Hypertension is one of the main factors causing cardiovascular diseases. The aim of the study is to investigate the effects of Chlorella pyrenoidosa on blood pressure and cardiorenal remodeling in rats with N ω-nitro-l-arginine methyl ester hydrochloride (L-NAME)-induced endothelial dysfunction.


Rats were fed a diet containing L-NAME (40 mg/kg) with or without chlorella (4 or 8 %) for 5 weeks. We found that chlorella retarded the development of hypertension and cardiorenal remodeling during the 5-week experimental period.


Although there was no difference in NO x levels or plasma arginine concentrations, plasma and tissues ACE activities were significantly lower in the chlorella groups than in the L-NAME group. Moreover, tissue tumor necrosis factor-α concentrations and renal CYP4A expression were also lower in the chlorella group.


These results suggest that chlorella might ameliorate the elevation of blood pressure and show cardiorenal-protective effects in nitric oxide-deficient rats, and one possible mechanism might be mediated by its ACE inhibitory activity.


Chlorella Hypertension Nitric oxide Angiotensin-converting enzyme 



All the authors have seen and approved the contents of the submitted manuscript. All the authors stated that there are no conflicts of interest, and all the authors adhere to the Committee on Publication Ethics guidelines on research and publication ethics. This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. The contribution of each author was as follows: Yi-Ching Yang, Hsiang-Chi Peng, Pei-Yin Ho: doing experiments; Su-Ching Yang, Hsin-Yi Yang: writing of the manuscript and designing the study.

Conflict of interest

All authors have no relevant conflict of interest to disclose.


  1. 1.
    Taddei S, Virdis A, Mattei P et al (1996) Defective l-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 94:1298–1303CrossRefGoogle Scholar
  2. 2.
    Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R (1992) Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20:298–303CrossRefGoogle Scholar
  3. 3.
    Ceconi C, Fox KM, Remme WJ et al (2007) ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res 73:237–246CrossRefGoogle Scholar
  4. 4.
    Miranda MS, Sato S, Mancini-Filho J (2001) Antioxidant activity of the microalga Chlorella vulgaris cultered on special conditions. Boll Chim Farm 140:165–168Google Scholar
  5. 5.
    Sansawa H, Takahashi M, Tsuchikura S, Endo H (2006) Effect of chlorella and its fractions on blood pressure, cerebral stroke lesions, and life-span in stroke-prone spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo) 52:457–466CrossRefGoogle Scholar
  6. 6.
    Merchant RE, Andre CA, Sica DA (2002) Nutritional supplementation with Chlorella pyrenoidosa for mild to moderate hypertension. J Med Food 5:141–152CrossRefGoogle Scholar
  7. 7.
    Griesmacher A, Kindhauser M, Andert SE et al (1995) Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 98:469–475CrossRefGoogle Scholar
  8. 8.
    Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62–71CrossRefGoogle Scholar
  9. 9.
    Shalaby SM, Zakora M, Otte J (2006) Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates. J Dairy Res 73:178–186CrossRefGoogle Scholar
  10. 10.
    Palm F, Nordquist L (2011) Renal oxidative stress, oxygenation, and hypertension. Am J Physiol Regul Integr Comp Physiol 301:R1229–R1241CrossRefGoogle Scholar
  11. 11.
    Sugamura K, Keaney JF Jr (2011) Reactive oxygen species in cardiovascular disease. Free Radic Biol Med 51:978–992CrossRefGoogle Scholar
  12. 12.
    Vijayavel K, Anbuselvam C, Balasubramanian MP (2007) Antioxidant effect of the marine algae Chlorella vulgaris against naphthalene-induced oxidative stress in the albino rats. Mol Cell Biochem 303:39–44CrossRefGoogle Scholar
  13. 13.
    Lee HS, Choi CY, Cho C, Song Y (2003) Attenuating effect of chlorella supplementation on oxidative stress and NFkappaB activation in peritoneal macrophages and liver of C57BL/6 mice fed on an atherogenic diet. Biosci Biotechnol Biochem 67:2083–2090CrossRefGoogle Scholar
  14. 14.
    Pechanova O, Simko F (2009) Chronic antioxidant therapy fails to ameliorate hypertension: potential mechanisms behind. J Hypertens 27(Suppl 6):S32–S36CrossRefGoogle Scholar
  15. 15.
    Napoli C, Sica V, de Nigris F et al (2004) Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. Am Heart J 148:e5CrossRefGoogle Scholar
  16. 16.
    Kitamoto S, Egashira K, Kataoka C et al (2000) Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II. J Hypertens 18:1795–1800CrossRefGoogle Scholar
  17. 17.
    Siani A, Pagano E, Iacone R et al (2000) Blood pressure and metabolic changes during dietary l-arginine supplementation in humans. Am J Hypertens 13:547–551CrossRefGoogle Scholar
  18. 18.
    Mann GE, Yudilevich DL, Sobrevia L (2003) Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 83:183–252Google Scholar
  19. 19.
    Ast J, Jablecka A, Bogdanski P et al (2010) Evaluation of the antihypertensive effect of l-arginine supplementation in patients with mild hypertension assessed with ambulatory blood pressure monitoring. Med Sci Monit 16:CR266–CR271Google Scholar
  20. 20.
    De Gennaro Colonna V, Rigamonti A, Fioretti S et al (2005) Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. Eur J Pharmacol 516:253–259CrossRefGoogle Scholar
  21. 21.
    Pereira LM, Almeida JR, Mandarim-de-Lacerda CA (2004) Kidney adaptation in nitric oxide-deficient Wistar and spontaneously hypertensive rats. Life Sci 74:1375–1386CrossRefGoogle Scholar
  22. 22.
    Vijan SG (2009) Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients. J Indian Med Assoc 107:178–182Google Scholar
  23. 23.
    Suetsuna K, Chen JR (2001) Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Mar Biotechnol (NY) 3:305–309CrossRefGoogle Scholar
  24. 24.
    Katoh M, Egashira K, Mitsui T et al (2000) Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis. J Mol Cell Cardiol 32:73–83CrossRefGoogle Scholar
  25. 25.
    Zhang H, Park Y, Wu J et al (2009) Role of TNF-alpha in vascular dysfunction. Clin Sci (Lond) 116:219–230CrossRefGoogle Scholar
  26. 26.
    Gonzalez W, Fontaine V, Pueyo ME et al (2000) Molecular plasticity of vascular wall during N(G)-nitro-l-arginine methyl ester-induced hypertension: modulation of proinflammatory signals. Hypertension 36:103–109CrossRefGoogle Scholar
  27. 27.
    Fogari R, Zoppi A (2005) Is the effect of antihypertensive drugs on platelet aggregability and fibrinolysis clinically relevant? Am J Cardiovasc Drugs 5:211–223CrossRefGoogle Scholar
  28. 28.
    Oyekan AO, Youseff T, Fulton D, Quilley J, McGiff JC (1999) Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride. J Clin Invest 104:1131–1137CrossRefGoogle Scholar
  29. 29.
    Huang H, Zhou Y, Raju VT et al (2005) Renal 20-HETE inhibition attenuates changes in renal hemodynamics induced by L-NAME treatment in pregnant rats. Am J Physiol Renal Physiol 289:F1116–F1122CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Su-Ching Yang
    • 1
  • Hsin-Yi Yang
    • 2
    Email author
  • Yi-Ching Yang
    • 1
    • 3
  • Hsiang-Chi Peng
    • 1
  • Pei-Yin Ho
    • 4
  1. 1.School of Nutrition and Health SciencesTaipei Medical UniversityTaipeiTaiwan
  2. 2.Department of NutritionI-Shou UniversityKaohsiung CityTaiwan
  3. 3.Department of NutritionShin-Kong Wu Ho-Su Memorial HospitalTaipeiTaiwan
  4. 4.Graduate Institute of OncologyNational Taiwan UniversityTaipeiTaiwan

Personalised recommendations